ClinVar Miner

Variants from Molecular Genetics and NGS Laboratory, Hospital Fundacion Valle Del Lili

Location: Colombia  Primary collection method: clinical testing
Minimum submission review status: Collection method:
Minimum conflict level:
Gene type:
ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic likely pathogenic uncertain significance likely benign benign total
28 22 1 0 0 51

Gene and significance breakdown #

Total genes and gene combinations: 46
Download table as spreadsheet
Gene or gene combination pathogenic likely pathogenic uncertain significance total
ABCB11 1 1 0 2
BRCA1 2 0 0 2
BRCA2 1 1 0 2
FBN1 0 2 0 2
SLC10A1 2 0 0 2
ABCC8 0 1 0 1
ANK2 1 0 0 1
ANKRD11 1 0 0 1
APC 0 1 0 1
ATM 0 1 0 1
ATP6V1A 0 1 0 1
BAP1 1 0 0 1
BMPR2 1 0 0 1
BRIP1 1 0 0 1
CAST, LOC101929710, PCSK1 0 1 0 1
CFTR 1 0 0 1
CFTR, LOC111674475 1 0 0 1
CHD7 1 0 0 1
CSNK2A1 0 1 0 1
CYLD 1 0 0 1
FLNB 1 0 0 1
FOXL2 0 1 0 1
GLI3 0 1 0 1
GRIN2B 1 0 0 1
HBB, LOC107133510, LOC110006319 1 0 0 1
HPGD 0 1 0 1
LIPC 0 1 0 1
LOC100507346, PTCH1 1 0 0 1
LOC107982234, WT1 0 1 0 1
MCM8 0 1 0 1
MLH1 0 1 0 1
MSH6 0 1 0 1
MUTYH 0 1 0 1
NLRP3 0 1 0 1
PANK2 1 0 0 1
PCNT 1 0 0 1
POLG, POLGARF 1 0 0 1
PROS1 0 1 0 1
RET 0 1 0 1
SGCG 1 0 0 1
SH3TC2 1 0 0 1
SPTA1 1 0 0 1
TP53 1 0 0 1
TRAPPC9 1 0 0 1
VWF 0 0 1 1
WT1 1 0 0 1

Condition and significance breakdown #

Total conditions: 45
Download table as spreadsheet
Condition pathogenic likely pathogenic uncertain significance total
Benign recurrent intrahepatic cholestasis type 2; Progressive familial intrahepatic cholestasis type 2 1 1 0 2
Breast-ovarian cancer, familial, susceptibility to, 1; Pancreatic cancer, susceptibility to, 4; Fanconi anemia, complementation group S 2 0 0 2
Bronchiectasis with or without elevated sweat chloride 1; Cystic fibrosis; Hereditary pancreatitis; Congenital bilateral aplasia of vas deferens from CFTR mutation 2 0 0 2
Familial cancer of breast 1 1 0 2
Hypercholanemia, familial, 2 2 0 0 2
Wilms tumor 1 1 1 0 2
Autosomal recessive cutis laxa type 2D; Epileptic encephalopathy, infantile or early childhood, 3 0 1 0 1
Autosomal recessive limb-girdle muscular dystrophy type 2C 1 0 0 1
Basal cell carcinoma, susceptibility to, 1; Gorlin syndrome; Holoprosencephaly 7 1 0 0 1
Body mass index quantitative trait locus 12; Obesity due to prohormone convertase I deficiency 0 1 0 1
Breast-ovarian cancer, familial, susceptibility to, 2 0 1 0 1
Brooke-Spiegler syndrome; Familial cylindromatosis; Trichoepithelioma, multiple familial, 1 1 0 0 1
CHARGE association; Hypogonadotropic hypogonadism 5 with or without anosmia 1 0 0 1
Cardiac arrhythmia, ankyrin-B-related 1 0 0 1
Charcot-Marie-Tooth disease type 4C 1 0 0 1
Chronic infantile neurological, cutaneous and articular syndrome; Keratitis fugax hereditaria; Familial amyloid nephropathy with urticaria AND deafness; Familial cold autoinflammatory syndrome 1; Hearing loss, autosomal dominant 34, with or without inflammation 0 1 0 1
Colorectal cancer, hereditary nonpolyposis, type 2 0 1 0 1
Dominant beta-thalassemia; Heinz body anemia; Hb SS disease; Malaria, susceptibility to; Methemoglobinemia, beta-globin type; Erythrocytosis, familial, 6; Hereditary persistence of fetal hemoglobin; Beta-thalassemia HBB/LCRB 1 0 0 1
Elliptocytosis 2 1 0 0 1
Endometrial carcinoma; Lynch syndrome 5 0 1 0 1
Familial adenomatous polyposis 1; Colorectal cancer 0 1 0 1
Familial adenomatous polyposis 2; Gastric cancer 0 1 0 1
Familial cancer of breast; Breast-ovarian cancer, familial, susceptibility to, 2; Fanconi anemia complementation group D1; Medulloblastoma; Wilms tumor 1; Malignant tumor of prostate; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3 1 0 0 1
Greig cephalopolysyndactyly syndrome; Pallister-Hall syndrome; Polysyndactyly 4; Polydactyly, postaxial, type A1 0 1 0 1
Hirschsprung disease, susceptibility to, 1; Familial medullary thyroid carcinoma 0 1 0 1
Hyperinsulinemic hypoglycemia, familial, 1; Leucine-induced hypoglycemia; Diabetes mellitus, permanent neonatal 3 0 1 0 1
Hypertrophic osteoarthropathy, primary, autosomal recessive, 1 0 1 0 1
Hypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration; Pigmentary pallidal degeneration 1 0 0 1
Intellectual disability, autosomal dominant 6 1 0 0 1
Intellectual disability, autosomal recessive 13 1 0 0 1
KBG syndrome 1 0 0 1
Larsen syndrome 1 0 0 1
Li-Fraumeni syndrome 1 1 0 0 1
Marfan syndrome 0 1 0 1
Melanoma, uveal, susceptibility to, 2; BAP1-related tumor predisposition syndrome; Kury-Isidor syndrome 1 0 0 1
Microcephalic osteodysplastic primordial dwarfism type II 1 0 0 1
Okur-Chung neurodevelopmental syndrome 0 1 0 1
Premature ovarian failure 10 0 1 0 1
Premature ovarian failure 3 0 1 0 1
Progressive sclerosing poliodystrophy; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 1; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 1; Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis; Mitochondrial DNA depletion syndrome 4b 1 0 0 1
Pulmonary hypertension, primary, 1; Pulmonary venoocclusive disease 1 1 0 0 1
Stiff skin syndrome 0 1 0 1
Thrombophilia due to protein S deficiency, autosomal dominant 0 1 0 1
Type 2 diabetes mellitus 0 1 0 1
von Willebrand disease type 1; von Willebrand disease type 3; von Willebrand disease type 2 0 0 1 1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.